Zai Lab Ltd (ZLAB)
27.16
-2.78
(-9.29%)
USD |
NASDAQ |
Nov 14, 13:05
Zai Lab Total Liabilities (Quarterly): 283.19M for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 283.19M |
| March 31, 2024 | 226.27M |
| December 31, 2023 | 240.18M |
| September 30, 2023 | 162.72M |
| June 30, 2023 | 174.06M |
| March 31, 2023 | 168.83M |
| December 31, 2022 | 174.54M |
| September 30, 2022 | 192.64M |
| June 30, 2022 | 206.61M |
| March 31, 2022 | 192.91M |
| December 31, 2021 | 230.00M |
| September 30, 2021 | 140.15M |
| June 30, 2021 | 223.52M |
| March 31, 2021 | 121.62M |
| Date | Value |
|---|---|
| December 31, 2020 | 128.29M |
| June 30, 2020 | 82.75M |
| December 31, 2019 | 60.49M |
| September 30, 2019 | 54.52M |
| June 30, 2019 | 53.13M |
| June 30, 2019 | 53.13M |
| December 31, 2018 | 50.91M |
| June 30, 2018 | 11.88M |
| June 30, 2018 | 11.88M |
| December 31, 2017 | 14.46M |
| June 30, 2017 | 175.02M |
| June 30, 2017 | 175.02M |
| December 31, 2016 | 140.46M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
60.49M
Minimum
Dec 2019
283.19M
Maximum
Jun 2024
176.99M
Average
174.54M
Median
Dec 2022
Total Liabilities (Quarterly) Benchmarks
| Concord Medical Services Holdings Ltd | 646.89M |
| WuXi Biologics (Cayman) Inc | 1.577B |
| Sinovac Biotech Ltd | 1.390B |
| CASI Pharmaceuticals Inc | 42.25M |
| Adagene Inc | 44.19M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 987.37M |
| Shareholders Equity (Quarterly) | 704.18M |
| Debt to Equity Ratio | 0.0998 |
| Current Ratio | 3.456 |
| Net Debt Paydown Yield | -0.83% |